消瘀康胶囊治疗老年慢性硬膜下血肿临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R651.1+5

基金项目:


Clinical Study on Xiaoyukang Capsules for Chronic Subdural Hematoma in the Senile
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察消瘀康胶囊联合阿托伐他汀治疗老年慢性硬膜下血肿的临床疗效。方法:将老年慢性硬膜下血肿患者65 例按照随机数字表法分为对照组32 例及治疗组33 例。对照组给予阿托伐他汀治疗,治疗组在对照组的基础上加用消瘀康胶囊。疗程均为12 周,观察比较2 组临床疗效,治疗前后血肿量及日常生活活动能力(ADL) 量表评分、日常生活能力(Barthel) 指数评分变化。结果:治疗组总有效率为90.91%,对照组为71.88%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组血肿量比较,差异无统计学意义(P>0.05);治疗后,2 组血肿量均较治疗前减少(P<0.05);且治疗组血肿量明显少于对照组(P<0.05)。治疗前,2 组ADL 量表评分、Barthel 指数评分比较,差异无统计学意义(P>0.05);治疗后,2 组ADL 评分较治疗前降低(P<0.05)、Barthel 指数评分较治疗前升高(P<0.05);且治疗组2 项指标改善较对照组更显著(P<0.05)。结论:消瘀康胶囊联合阿托伐他汀治疗老年慢性硬膜下血肿可提高临床疗效,促进血肿吸收,有效改善患者日常生活活动能力。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Xiaoyukang capsules combined with atorvastatin for chronic subdural hematoma in the senile. Methods: A total of 65 cases of senile patients with chronic subdural hematoma were divided into the control group and the treatment group according to the random number table method,32 and 33 cases in each group respectively. The control group was treated with atorvastatin,and the treatment group was additionally treated with Xiaoyukang capsules based on the treatment of the control group. Both groups were treated for 12 weeks. The changes in hematoma volume and scores of Activities of Daily Living(ADL) and Barthel indexes before and after treatment and the clinical effect in the two groups were observed and compared. Results:The total effective rate was 90.91% in the treatment group and 71.88% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of hematoma volume between the two groups(P>0.05); after treatment, the hematoma volume in the two groups was decreased when compared with that before treatment(P<0.05),and the one in the treatment group was significantly less than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the scores of ADL and Barthel indexes between the two groups(P>0.05);after treatment,the ADL score decreased and Barthel index score increased in both groups(P<0.05);The improvement of two indexes in the treatment group was more significant than that in the control group(P<0.05). Conclusion:Xiaoyukang capsule combined with atorvastatin for chronic subdural hematoma in senile patients can improve their clinical effect, promote hematoma absorption,and effectively improve the activities of daily living.

    参考文献
    相似文献
    引证文献
引用本文

张佳克,方锦,刘海龙,安海龙.消瘀康胶囊治疗老年慢性硬膜下血肿临床研究[J].新中医,2021,53(12):78-81

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-06-23
  • 出版日期:
文章二维码